Prevalence of Cervical Extension of the ThymusCETNCT05228977
Prevalence of Cervical Extension of the Thymus in Children
An observational study of Prevalence of Cervical Extension of the Thymus, run by Kabul University of Medical Sciences at 2 sites in Afghanistan.
Trial summary
This prospective, observational study included all pediatric patients who were referred to the radiology department for neck ultrasonography between August-October 2018. A high-frequency probe was implemented and 220 patients were examined. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Prevalence of Cervical Extension of the Thymus
- How many people
- 220 participants
- Where
- 2 sitesAfghanistan
- Study dates
- 1 Aug 2018to 30 Oct 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients referred to the radiology department for the neck US with various clinical indications between August-October 2018 were included in the study.
Who may be able to join
- The patients referred to the radiology department for the neck US with various clinical indications between August-October 2018 were included in the study.
Who cannot join
- The patients who had any systemic illness, were treated for malignancy, or had any history of lower neck or chest surgery, were excluded.
Trial locations and contacts
2 sites in 1 country.
Afghanistan2 sites
Habib Ahmad Esmat
Kabul, None Selected, 35030
KUMs
Kabul, 35030
About this study
Official title: Prevalence of Cervical Extension of the Thymus in Children- A Prospective Study
This prospective, observational study included all pediatric patients who were referred to the radiology department for neck ultrasonography between August-October 2018. A high-frequency probe was implemented and 220 patients were examined.
Read the detailed description
This prospective single-centered study was approved by the Institutional Review Board for Ethical Issues in Clinical Research and is compatible with the Declaration of Helsinki. The patients referred to the radiology department for the neck US with various clinical indications between August-October 2018 were included in the study. The informed consent was taken from the parents of the patients. The patients who had any systemic illness, were treated for malignancy or had any history of lower neck or chest surgery, were excluded.
The neck US was performed by two radiologists. The length of the extended thymus, from the upper margin of the manubrium to the superior edge of the thymic tissue on the transverse plane, was measured in millimeters and recorded.
al analysis of the data was performed in SPSS, Version 24 program (IBM, Armonk, New York). Pearson Chi-Square Test was used in comparing categorical data between groups.
- Keywords
- Thymus; Cervical extension; Pediatrics;
What is being measured
The primary outcome is the main question the study is designed to answer.
0
As our trial has no intervention, so there were no positive or negative primary effects
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2022
- Study start1 Aug 2018
- Primary completion1 Oct 2018
- Study completion30 Oct 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Prevalence of Cervical Extension of the ThymusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 220 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kabul University of Medical Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Habib Ahmad Esmat, Kabul University of Medical Sciences
- Investigators
- Mohammad wali Nasary, MD, Study director, KMUs
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05228977
- Sponsor's protocol ID
- 0002
- Acronym
- CET
- Status last verified
- Feb 2022
- First submitted
- 26 Jan 2022
- Last updated
- 8 Feb 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Feb 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Cervical Extension of the Thymus in Children- A Prospective Study
- ClinicalTrials.gov ID
- NCT05228977
- Acronym / sponsor ID
- CET / 0002
- Keywords
- Thymus; Cervical extension; Pediatrics;
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 220 participants (actual)
- Lead sponsor
- Kabul University of Medical SciencesUniversity, hospital or other
- Study start
- 1 Aug 2018 (actual)
- Primary completion
- 1 Oct 2018 (actual)
- Study completion
- 30 Oct 2018 (actual)
- First posted
- 8 Feb 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective, observational study included all pediatric patients who were referred to the radiology department for neck ultrasonography between August-October 2018. A high-frequency probe was implemented and 220 patients were examined.
Detailed description
This prospective single-centered study was approved by the Institutional Review Board for Ethical Issues in Clinical Research and is compatible with the Declaration of Helsinki. The patients referred to the radiology department for the neck US with various clinical indications between August-October 2018 were included in the study. The informed consent was taken from the parents of the patients. The patients who had any systemic illness, were treated for malignancy or had any history of lower neck or chest surgery, were excluded.
The neck US was performed by two radiologists. The length of the extended thymus, from the upper margin of the manubrium to the superior edge of the thymic tissue on the transverse plane, was measured in millimeters and recorded.
al analysis of the data was performed in SPSS, Version 24 program (IBM, Armonk, New York). Pearson Chi-Square Test was used in comparing categorical data between groups.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients referred to the radiology department for the neck US with various clinical indications between August-October 2018 were included in the study.
Key inclusion criteria (1 listed)
- The patients referred to the radiology department for the neck US with various clinical indications between August-October 2018 were included in the study.
Key exclusion criteria (1 listed)
- The patients who had any systemic illness, were treated for malignancy, or had any history of lower neck or chest surgery, were excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
0
Time frame: 3 months
As our trial has no intervention, so there were no positive or negative primary effects
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Feb 2022.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohammad wali Nasary, MD study director
KMUs
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Prevalence of Cervical Extension of the Thymus, run by Kabul University of Medical Sciences at 2 sites in Afghanistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Afghanistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
0 (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2022.